Home > Insider Trading > Filing (0001209191-12-044070)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885978	U S Physical Therapy Inc	USPH	Services-Health Services (8000)	760364866

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1270356	J Christopher Reading	1300 W. Sam Houston Pkwy S. Suite 300 Houston TX 77042	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-08-30	100,000	$13.54	163,323	No	4	M	Direct
Common Stock	Disposition	2012-08-30	49,907	$27.13	113,416	No	4	F	Direct
Common Stock	Disposition	2012-08-31	21,556	$26.02	91,860	No	4	S	Direct
Common Stock	Disposition	2012-09-04	28,537	$26.38	63,323	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Director's Stock Option Right to Buy	Disposition	2012-08-30	100,000	$0.00	100,000	$13.54

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
50,000	2012-08-30	2014-10-05	No	4	M	Direct

Footnotes

Includes 18,750 restricted shares in which restrictions lapse in equal quarterly installments of 1,875 shares with the next installment on September 30, 2012 and the last on December 31, 2014. Also, includes 20,214 shares of common stock granted as restricted stock. Restrictions lapse in equal quarterly installments of 1,443 shares with the next installment on September 30, 2012, and the final installment of 1,455 shares on December 31, 2015.
Surrender of shares in connection with cashless exercise
The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.00- $26.29, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.00- $26.99, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Granted pursuant to the Company's 2003 Stock Incentive Plan, which complies with Rule 16b-3.